SEOM clinical guideline in nasopharynx cancer (2017)
Clin. transl. oncol. (Print)
; 20(1): 84-88, ene. 2018. tab
Article
en En
| IBECS
| ID: ibc-170471
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time (AU)
RESUMEN
No disponible
Texto completo:
1
Banco de datos:
IBECS
Asunto principal:
Carcinoma de Células Escamosas
/
Neoplasias Nasofaríngeas
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Año:
2018
Tipo del documento:
Article